Nautilus Biotechnolgy, Inc. Common Stock

Go to Nautilus Biotechnolgy, Inc. Common Stock Website

$0.74

0.00 (0.00%)
Live
Previous Close

$0.741

Day Range

$0 - $0

Previous Day Range

$0.73 - $0.770001

Market Cap

$96.4 million USD

Day Vol.

0

Previous Day Vol.

85226

Currency

USD

Primary Exchange

Nasdaq

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the pr...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Nautilus Biotechnology (NAUT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Related tickers: NAUT.

Read Full Article

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2024.

Related tickers: NAUT.

Read Full Article
Trending Tickers

Please sign in to view